PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
基本信息
- 批准号:6534032
- 负责人:
- 金额:$ 48.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:HY antigen MHC class I antigen MHC class II antigen antigen presentation bioimaging /biomedical imaging biomedical equipment development capillary electrophoresis cross immunity electrospray ionization mass spectrometry graft versus host disease high performance liquid chromatography histocompatibility antigens melanoma multiple sclerosis myelin basic proteins protein sequence tumor antigens
项目摘要
DESCRIPTION: (adapted from applicant's abstract) Research to continue the
development of instrumentation and methods for the sequence analysis of peptide
antigens presented to the immune system in association with class I and class
II molecules of the major histocompatibility complex is proposed. Routine
detection and characterization of disease associated antigens present at the
attomole level in a mixture of 10,000 self peptides is the expected outcome.
Identification of disease associated antigens is an important first step in the
development of vaccines or other immune system modulators that are effective
against bacterial and viral infections, cancer, autoimmune disorders and tissue
transplant rejection. Multistage chromatography in conjunction with our
recently developed, automated peak parking technology plus nanoliter/min, high
performance liquid chromatography and high performance capillary
electrophoresis interfaced to an ion trap mass spectrometer via an electrospray
ionization source will be employed to achieve this goal. Specific aims of the
proposed research include the following: (1) to identify melanoma specific
antigens presented by the class I molecules, HLA A2.1, A1 and A3, and the class
II molecule, DR4, (2) to identify minor histocompatibility antigens associated
with graft-vs-host disease and tissue transplant rejection, (3) to identify
peptides derived from myelin basic protein as well as cross reactive self
peptides that are presented by the multiple sclerosis associated class II
molecule, DR15Dw2, and recognized by T-cell clones derived from multiple
sclerosis patients, (4) to identify peptides presented by the class I molecule,
B27, that are unique to individuals diagnosed with ankylosing spondylitis (5)
to identify peptides presented by the class I molecule, A2.1, that are unique
to individuals diagnosed as having chronic lymphocytic leukemia, (6) to
identify and characterize peptides presented by HLA-A2.1, that have been post
translationally modified by either phosphorylation or glycosylation, (7) to
identify class II peptides presented by the HLA-DR4Dw4 molecule in the presence
and absence of the chaperone molecule, HLA-DM.
描述:(改编自申请者摘要)继续研究
多肽序列分析仪器和方法的发展
与第I类和第I类有关的抗原呈递给免疫系统
提出了主要组织相容性复合体的II类分子。例程
疾病相关抗原的检测和表征
10,000个自体多肽混合物中的阿托莫尔水平是预期结果。
疾病相关抗原的鉴定是疾病研究的重要第一步
开发有效的疫苗或其他免疫系统调节剂
对抗细菌和病毒感染、癌症、自身免疫性疾病和组织
移植排斥反应。多阶段层析与我们的
最新开发的自动高峰停车技术,加上纳升/分钟,高
高效液相色谱和高效毛细管
通过电喷雾将电泳法与离子陷阱质谱仪对接
将使用电离源来实现这一目标。《公约》的具体目标
建议的研究包括以下内容:(1)鉴定黑色素瘤特异性
由I类分子,人类白细胞抗原A2.1,A1和A3提出的抗原,以及类
II分子,DR4,(2),用于识别与之相关的次要组织相容性抗原
移植物抗宿主病和组织移植排斥反应,(3)识别
髓鞘碱性蛋白来源的多肽与交叉反应自身
多发性硬化症相关II类递呈的多肽
分子DR15Dw2,并被来自多个来源的T细胞克隆识别
硬化症患者,(4)鉴定I类分子呈递的多肽,
B27,是强直性脊柱炎患者所特有的(5)
为了鉴定由I类分子A2.1呈现的独特的多肽
对诊断为慢性淋巴细胞白血病的个人,(6)至
鉴定和鉴定已发布的由人类白细胞抗原-A2.1呈递的多肽
通过磷酸化或糖基化进行翻译修饰,(7)到
鉴定存在的人类白细胞抗原-DR4Dw4分子呈递的II类肽
以及缺乏伴侣分子,即人类白细胞抗原-DM。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD F HUNT其他文献
DONALD F HUNT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD F HUNT', 18)}}的其他基金
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
6373317 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
6653813 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
6943743 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
Processed Antigen Characterization by Mass Spectrometry
通过质谱分析处理抗原表征
- 批准号:
8115926 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
2697497 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
Processed Antigen Characterization by Mass Spectrometry
通过质谱分析处理抗原表征
- 批准号:
7917390 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
6170021 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
6911650 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
通过质谱法进行抗原表征
- 批准号:
7456406 - 财政年份:1999
- 资助金额:
$ 48.38万 - 项目类别:
相似海外基金
Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
- 批准号:
486527 - 财政年份:2022
- 资助金额:
$ 48.38万 - 项目类别:
Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
- 批准号:
nhmrc : GNT1164054 - 财政年份:2020
- 资助金额:
$ 48.38万 - 项目类别:
Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8996707 - 财政年份:2014
- 资助金额:
$ 48.38万 - 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
- 批准号:
8880646 - 财政年份:2014
- 资助金额:
$ 48.38万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
9206412 - 财政年份:2014
- 资助金额:
$ 48.38万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8723605 - 财政年份:2014
- 资助金额:
$ 48.38万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
8072956 - 财政年份:2010
- 资助金额:
$ 48.38万 - 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
- 批准号:
105348415 - 财政年份:2009
- 资助金额:
$ 48.38万 - 项目类别:
Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
- 批准号:
5354871 - 财政年份:2002
- 资助金额:
$ 48.38万 - 项目类别:
Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7991835 - 财政年份:2001
- 资助金额:
$ 48.38万 - 项目类别: